PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34697629-0	2022	GlcNAc-Asn (GNA) is a biomarker for NGLY1 deficiency.	N-acetylglucosaminylasparagine	0-10	N-glycanase 1	Homo sapiens	36-41	
34697629-3	2022	We demonstrate that N-acetylglucosamine-asparagine (GlcNAc-Asn; GNA), is the analyte most closely associated with NGLY1 deficiency, showing consistent separation in levels between patients and controls.	N-acetylglucosaminylasparagine	52-62	N-glycanase 1	Homo sapiens	114-119	
31311714-0	2019	Aspartylglycosamine is a biomarker for NGLY1-CDDG, a congenital disorder of deglycosylation.	N-acetylglucosaminylasparagine	0-19	N-glycanase 1	Homo sapiens	39-44	
31311714-0	2019	Aspartylglycosamine is a biomarker for NGLY1-CDDG, a congenital disorder of deglycosylation.	N-acetylglucosaminylasparagine	0-19	N-glycanase 1	Homo sapiens	45-49	
31311714-6	2019	RESULTS: We identified aspartylglycosamine as the only significantly increased compound with a median Z-score of 4.8 (range: 3.8-8.5) in DBS of NGLY1-CDDG patients, compared to a median Z-score of -0.1 (range: -2.1-4.0) in DBS of healthy controls and patients with other diseases.	N-acetylglucosaminylasparagine	23-42	N-glycanase 1	Homo sapiens	144-149	
31311714-6	2019	RESULTS: We identified aspartylglycosamine as the only significantly increased compound with a median Z-score of 4.8 (range: 3.8-8.5) in DBS of NGLY1-CDDG patients, compared to a median Z-score of -0.1 (range: -2.1-4.0) in DBS of healthy controls and patients with other diseases.	N-acetylglucosaminylasparagine	23-42	N-glycanase 1	Homo sapiens	150-154	
31311714-7	2019	DISCUSSION: The increase of aspartylglycosamine can be explained by lack of function of PNG.	N-acetylglucosaminylasparagine	28-47	N-glycanase 1	Homo sapiens	88-91	
31311714-10	2019	Thus, we here identified aspartylglycosamine as the first potential small-molecule biomarker in DBS for NGLY1-CDDG, making a biochemical diagnosis for NGLY1-CDDG potentially feasible.	N-acetylglucosaminylasparagine	25-44	N-glycanase 1	Homo sapiens	104-109	
31311714-10	2019	Thus, we here identified aspartylglycosamine as the first potential small-molecule biomarker in DBS for NGLY1-CDDG, making a biochemical diagnosis for NGLY1-CDDG potentially feasible.	N-acetylglucosaminylasparagine	25-44	N-glycanase 1	Homo sapiens	110-114	
31311714-10	2019	Thus, we here identified aspartylglycosamine as the first potential small-molecule biomarker in DBS for NGLY1-CDDG, making a biochemical diagnosis for NGLY1-CDDG potentially feasible.	N-acetylglucosaminylasparagine	25-44	N-glycanase 1	Homo sapiens	151-156	
31311714-10	2019	Thus, we here identified aspartylglycosamine as the first potential small-molecule biomarker in DBS for NGLY1-CDDG, making a biochemical diagnosis for NGLY1-CDDG potentially feasible.	N-acetylglucosaminylasparagine	25-44	N-glycanase 1	Homo sapiens	157-161